Janux Therapeutics Ownership | Who Owns Janux Therapeutics?
Janux Therapeutics Ownership Summary
Janux Therapeutics is owned by 23.57% institutional investors, 6.73% insiders, and 69.71% retail investors. Ra capital management is the largest institutional shareholder, holding 18.06% of JANX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.67% of its assets in Janux Therapeutics shares.
JANX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Janux Therapeutics | 23.57% | 6.73% | 69.71% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 11.19M | 18.06% | $155.54M |
| Blackrock funding, inc. /de | 5.43M | 8.77% | $75.52M |
| Janus henderson group | 4.20M | 6.77% | $58.28M |
| Prosight management, lp | 3.55M | 5.73% | $49.34M |
| Blackrock | 2.34M | 4.78% | $98.19M |
| Paradigm biocapital advisors lp | 2.92M | 4.72% | $71.37M |
| Vanguard group | 2.91M | 4.69% | $40.11M |
| Fmr | 2.54M | 4.09% | $35.25M |
| State street | 2.46M | 3.98% | $34.25M |
| Tcg crossover management | 1.79M | 2.89% | $24.88M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Avalon ventures management | 53.30K | 9.17% | $1.30M |
| Prosight management, lp | 3.55M | 8.09% | $49.34M |
| Bioimpact capital | 614.28K | 2.46% | $15.01M |
| Paradigm biocapital advisors lp | 2.92M | 2.03% | $71.37M |
| Rangeley capital | 122.50K | 1.65% | $1.70M |
| Ra capital management | 11.19M | 1.65% | $155.54M |
| Lion point capital, lp | 19.00K | 1.58% | $264.10K |
| Bml capital management | 154.96K | 1.38% | $2.15M |
| Adar1 capital management | 351.03K | 0.81% | $8.58M |
| Tcg crossover management | 1.79M | 0.71% | $24.88M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 5.43M | 0.00% | 1.35M |
| Prosight management, lp | 3.55M | 8.09% | 1.16M |
| Deep track capital, lp | 1.19M | 0.27% | 1.10M |
| Holocene advisors, lp | 1.02M | 0.17% | 1.02M |
| Nantahala capital management | 809.91K | 0.41% | 809.91K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | - | - | -1.47M |
| State street | 2.46M | 0.00% | -1.39M |
| Janus henderson group | 4.20M | 0.03% | -1.15M |
| Rtw investments, lp | - | - | -1.00M |
| Fmr | 2.54M | 0.00% | -976.66K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Holocene advisors, lp | 1.02M | 0.17% | 1.02M | $54.35M |
| Nantahala capital management | 809.91K | 0.41% | 809.91K | $11.26M |
| Vanguard fiduciary trust | 313.65K | 0.00% | 313.65K | $4.36M |
| Bml capital management | 154.96K | 1.38% | 154.96K | $2.15M |
| Connor, clark & lunn investment management | 119.38K | 0.00% | 119.38K | $1.66M |
Sold Out
| Holder | Change |
|---|---|
| Corecap advisors | -9.00 |
| Srs capital advisors | -14.00 |
| Stephens consulting | -15.00 |
| Capital performance advisors llp | -17.00 |
| Abich financial wealth management | -20.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 117 | -37.77% | 14,603,619 | -76.52% | 23 | 0.23% | 73 | -35.96% | 23 | -43.90% |
| Dec 31, 2025 | 139 | -23.20% | 36,407,138 | -44.13% | 58 | 0.53% | 83 | 2.47% | 29 | -53.23% |
| Sep 30, 2025 | 172 | -1.71% | 64,553,591 | 1.68% | 104 | 0.99% | 79 | -14.13% | 59 | 15.69% |
| Jun 30, 2025 | 180 | -6.25% | 65,438,049 | -1.58% | 105 | 0.91% | 93 | -21.19% | 53 | 23.26% |
| Mar 31, 2025 | 7 | -96.93% | 3,447,727 | -94.63% | 5 | 0.04% | 5 | -96.82% | 1 | -97.73% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 2.20M | 3.67% | 2.89K |
| Fidelity Growth Compy Commingled Pl O | 1.65M | 3.16% | 20.65K |
| State Street® SPDR® S&P® Biotech ETF | 1.59M | 2.60% | -15.70K |
| Fidelity Growth Company Fund | 1.56M | 2.60% | -9.34K |
| Vanguard Total Stock Mkt Idx Inv | 1.23M | 2.01% | - |
| Vanguard US Total Market Shares ETF | 1.00M | 1.69% | 193.50K |
| iShares Russell 2000 ETF | 1.01M | 1.66% | 8.51K |
| FIAM Small Cap Core CIT Cl B | 912.40K | 1.50% | - |
| FIAM Small Cap Core Composite | 734.90K | 1.21% | 734.90K |
| Janus Henderson Global Life Sciences | 719.78K | 1.18% | 754.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 11, 2026 | Dobek Maria | Vice President, Accounting | Sell | $28.88K |
| Jan 02, 2026 | Meyer Andrew Hollman | Chief Business Officer | Sell | $25.80K |
| Jan 02, 2026 | DiRaimondo Thomas | Chief Scientific Officer | Sell | $34.39K |
| Jan 02, 2026 | Campbell David Alan | President and CEO | Sell | $110.83K |
| Jan 02, 2026 | Winter Charles M. | Chief Technical Officer | Sell | $32.97K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 1 |
| 2026 Q1 | - | 6 |
| 2025 Q4 | - | 4 |
| 2025 Q2 | - | 3 |
| 2025 Q1 | 4 | 11 |
JANX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools